Inventor · disambiguated record
Jarmo Pystynen
Also filed as: LOENNBERG KARI KALEVI · PYSTYNEN JARMO · PYSTYNEN JARMO J
20 granted patents·6 pending applications·558 citations·filing 1987–2021
95Inventor score
Top patents by PatentIndex Score
26 records- 0196US5446194APharmacologically active catechol derivativesORION YHTYMAE OY·Filed 1993·Granted Aug 29, 1995·108 cites·4 claims
- 0296US4963590APharmacologically active compounds, methods for the preparation thereof and compositions containing the sameORION YHTYMAE OY·Filed 1987·Granted Oct 16, 1990·156 cites·14 claims
- 0395US5283352APharmacologically active compounds, methods for the preparation thereof and compositions containing the sameORION YHTYMAE OY·Filed 1992·Granted Feb 1, 1994·60 cites·3 claims
- 0490US6903114B2Derivatives of naphthalene with COMT inhibiting activityORION CORP·Filed 2001·Granted Jun 7, 2005·37 cites·16 claims
- 0584US5151420ASubstituted pyridazinonesORION CORP ORION PHARMACEUTICA·Filed 1990·Granted Sep 29, 1992·38 cites·12 claims
- 0682US5112861AMethod of treating parkinson's disease using pentanedione derivativesORION YHTYMAE OY·Filed 1990·Granted May 12, 1992·48 cites·16 claims
- 0774US5292771ASubstituted β-diketones and their useORION YHTYMAE OY·Filed 1992·Granted Mar 8, 1994·12 cites·12 claims
- 0871US5185370ASubstituted β-diketones and their useORION YHTYMAE OY·Filed 1991·Granted Feb 9, 1993·10 cites·9 claims
- 0969US6150412ACatechol derivativesORION YHTYMAE OY·Filed 1996·Granted Nov 21, 2000·30 cites·9 claims
- 1069US2022047540A1Catechol o-methyltransferase activity inhibiting compoundsORION CORP·Filed 2021·Application pending·0 cites
- 1165US2020352898A1Catechol o-methyltransferase activity inhibiting compoundsORION CORP·Filed 2020·Application pending·0 cites
- 1259US6265421B1Phospholamban inhibitors and a method for increasing coronary flowORION CORP·Filed 1999·Granted Jul 24, 2001·21 cites·33 claims
- 1358US2019029990A1Catechol o-methyltransferase activity inhibiting compoundsORION CORP·Filed 2018·Application pending·0 cites
- 1456US4963677AHeterocyclic lactam compoundsORION YHTYMAE OY·Filed 1988·Granted Oct 16, 1990·5 cites·6 claims
- 1555US9458128B2Catechol O-methyltransferase activity inhibiting compoundsORION CORP·Filed 2013·Granted Oct 4, 2016·0 cites·52 claims
- 1654US6951870B2Coumarin derivatives with COMT inhibiting activityORION CORP·Filed 2001·Granted Oct 4, 2005·1 cites·15 claims
- 1754US5019575ANovel pyridazinone compounds, compositions thereof and method of useORION YHTYMAE OY·Filed 1990·Granted May 28, 1991·9 cites·13 claims
- 1853US5968959AMethod for the prevention and treatment of stunned myocardiumORION CORP·Filed 1998·Granted Oct 19, 1999·15 cites·23 claims
- 1953US2017165219A1Catechol o-methyltransferase activity inhibiting compoundsORION CORP·Filed 2016·Application pending·0 cites
- 2051US5185332AThiadiazines and pharmaceutical compositions thereof as well as method of useORION YHTYMAE OY·Filed 1991·Granted Feb 9, 1993·4 cites·11 claims
- 2142US5122524ATriazinone compounds compositions thereof and metal of useORION YHTYMAE OY·Filed 1991·Granted Jun 16, 1992·4 cites·10 claims
- 2239US2022002232A1Process for the preparation of 4,5-dihydroxy-2-(4-methylbenzyl)isophthalonitrileORION CORP·Filed 2019·Application pending·0 cites
- 2338US6699868B2Pyridazinyl phenyl hydrazones useful against congestive heart failureORION CORP·Filed 2001·Granted Mar 2, 2004·0 cites·11 claims
- 2435US8318785B2Pharmaceutical compoundsAHLMARK MARKO·Filed 2006·Granted Nov 27, 2012·0 cites·28 claims
- 2532US10774074B22-(1-heteroarylpiperazin-4-yl)methyl-1,4-benzodioxane derivatives as alpha2C antagonistsORION CORP·Filed 2016·Granted Sep 15, 2020·0 cites·21 claims
- 2629US2019152992A1Benzodioxane derivatives and their pharmaceutical useORION CORP·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →